Ceplene, ett särläkemedel för behandling av cancersjukdomen akut myeloid leukemi, AML, ingår i högkostnadsskyddet från och med den 3 maj 2011. Särläkemedel används mot mycket sällsynta och allvarliga sjukdomar. Den sjukdom som ett särläkemedel behandlar får högst förekomma hos 5 av 10 000 personer inom EU.
Jul 7, 2017 Specifically, the investigators identified that approximately 60% of the AML patients who had received treatment with Ceplene/IL-2 harbored NK
Ceplene is a medicine used in combination with interleukin -2 (a cancer medicine) as maintenance treatment in adults with acute myeloid leukaemia (AML), a type of cancer affe cting the white blood cells. Histamine dihydrochloride. Histamine dihydrochloride ( INN, trade name Ceplene) is a salt of histamine that is used as a drug for the prevention of relapse in patients diagnosed with acute myeloid leukemia (AML). It is also an FDA-approved active ingredient for topical analgesic use for the temporary relief of minor aches and pains of muscles and Janusmed fosterpåverkan – Ceplene Janusmed fosterpåverkan tillhandahåller bedömningar av eventuella risker för fostret, när en gravid kvinna använder olika läkemedel. Observera att texterna är generella, och att en bedömning måste göras i varje enskilt fall. Ceplene är en injektionsvätska, lösning innehållande aktiv substans histamin dihydroklorid ( 0, 5 mg / 0, 5 ml).
Histamine dihydrochloride (INN, trade name Ceplene) is a salt of histamine that is used as a drug for the prevention of relapse in patients diagnosed with acute myeloid leukemia (AML). Ceplene (histamine dihydrochloride) is intended for use in conjunction with interleukin-2 (IL-2) as a remission maintenance treatment of acute myeloid leukemia. Ceplene maintainance therapy is indicated for adult patients with acute myeloid leukaemia in first remission concomitantly treated with interleukin-2 (IL-2). The efficacy of Ceplene has not been fully demonstrated in patients older than age 60. Ceplene should be administered 1 to 3 minutes after IL-2 administration, and not concomitantly. Rapid subcutaneous injection or injection into a vascular space may result in severe hypotension, tachycardia, or syncope. Treatment with Ceplene in conjunction with IL-2 should be used with caution in patients with poorly compensated cardiac function.
BioCentury | Nov 18 EpiCept Corporation (NASDAQ: EPCT)(“EpiCept”) has entered into an exclusive commercialization agreement with Meda AB to market its Ceplene novel Jun 21, 2012 Ceplene injection contains the active ingredient histamine dihydrochloride, which is a type of medicine known as an immunomodulator. Jul 7, 2017 Specifically, the investigators identified that approximately 60% of the AML patients who had received treatment with Ceplene/IL-2 harbored NK Overview. Ceplene is a medicine used in combination with interleukin-2 (a cancer medicine) as maintenance treatment in adults with acute myeloid leukaemia ( Nov 2, 2010 The Minister had decided that Epicept's drug product CEPLENE® (histamine dihydrochloride), which is used for remission maintenance Mar 16, 2012 During this time, Caelyx and Ceplene continue to be manufactured at the Ben Venue facility, because it is the only site where these medicines are Jul 25, 2012 Acute myeloid leukaemia: Ceplene® as maintenance therapy in AML. teaser.
Outcome Measures: Primary: To assess the quantitative and qualitative pharmacodynamic effects of Ceplene plus low-dose IL-2 (Ceplene/IL-2) by monitoring T and natural killer (NK) cell phenotypes and their functionality after the first and third treatment cycles in adult patients with acute myeloid leukemia (AML) in first complete remission (CR1).
Vad används Ceplene för? Ceplene används i kombination med interleukin-2 (en cancer mot cancer) vid underhållsbehandling av vuxna patienter med akut myeloid leukemi, en typ av cancer som påverkar vita blodkroppar. Ceplene verkar genom att skydda immunsystemets celler från skador, att det förstärker effekten av IL-2, ett läkemedel som stimulerar immunsystemet till att angripa cancerceller. När Ceplene ges tillsammans med IL-2 hjälper det immunsystemet att döda de leukemiceller som finns kvar i kroppen under remission.
EU-kommissionen har gett ett marknadsgodkännande för Epicepts preparat Ceplene för behandling av blodcancersjukdomen akut myleoisk leukemi, AML.
Ceplene should be used with caution in patients who have severe problems with their kidneys or moderate to severe problems with their liver. Ceplene is not recommended for use in patients below 18 years of age because of a lack of information on safety and effectiveness in this age group. How does Ceplene work? Om Ceplene Ceplene är EpiCepts nypatenterade förening för behandling av AML. Ceplene är designad att skydda lymfocyter, vilka ansvarar för immun-medlande destruktion av överblivna leukemiceller.
NOVENTIA PHARMA SRL. regarding the. the European market authorizations of Ceplene® and other products of Cytovia. INJEKSJONSVÆSKE, oppløsning 0,5 mg/0,5 ml: 0,5 ml inneh.: Histamindihydroklorid 0,5 mg.
Periodisering inntekter konto
NOVENTIA PHARMA SRL. regarding the. the European market authorizations of Ceplene® and other products of Cytovia.
Djurstudier tyder inte på negativa effekter på fosterutvecklingen. Läkemedlet ska dock alltid ges tillsammans med interleukin 2 (aldesleukin) som har visat fosterskadande effekter i djurförsök. 2010-09-02 · Inlägg om Ceplene skrivna av outperform. Outperform's Blogg.
Hans kelsen legal positivism
mafa abkürzung
hoja gransen for statlig skatt
soker jobb underskoterska
willys timrå jobb
regions online
tandläkare malmö antagning
Immune Pharmaceuticals Inc. (NASDAQ: IMNP) ('Immune') announced today that it has signed an agreement with Meda, a Mylan NV company ('Mylan') to repurchase assets relating to Ceplene, including the right to commercialize Ceplene in Europe and to register and commercialize Ceplene in certain other countries.
Ceplene is approved in Europe for remission maintenance and prevention of relapse in adults with Acute Myeloid Leukemia, an orphan indication with poor survival prognosis, for which no effective therapy is available to patients.
Jan Urban Kristoffer Hellstrand, född 6 augusti 1956 i Annedal i Göteborg, [1] är en svensk läkare och professor i tumörimmunologi vid Göteborgs universitet.Han disputerade 1987 som medicine doktor, blev docent nästföljande år, utnämndes till professor 2003 och var vicedekanus vid Sahlgrenska akademin 2010-15.
Composición de Ceplene El principio activo es dihidrocloruro de histamina. Kód SÚKL, 0500730. Registrovaný název LP, CEPLENE. Název LP i, CEPLENE. Doplněk názvu, 0,5MG/0,5ML INJ SOL 14X0,5ML. Síla, 0,5MG/0,5ML.
Histamine dihydrochloride. Histamine dihydrochloride ( INN, trade name Ceplene) is a salt of histamine that is used as a drug for the prevention of relapse in patients diagnosed with acute myeloid leukemia (AML).